
Mako PKA
Together we can transform Orthopaedics
More info"We're excited to welcome Mako into our organisation and combine their expertise in robotic arm assisted surgery with Stryker's innovations in joint reconstruction to further advance the growth of this compelling technology. The long-term potential offered by this technology platform holds the promise of transforming reconstructive surgery, increasing patient satisfaction and enhancing the experience for surgeons and hospital."
Kevin A. Lobo
President and CEO
Stryker acquired Mako Surgical Corporation in December 2013 with the goal of transforming the orthopaedic industry. The acquisition combines Stryker's market-leading implants enabled by Mako's proprietary robotic-arm assisted technology. The current Mako System offers Total Hip, Partial Knee and Total Knee arthroplasty applications.
Patient Specific Pre-operative Planning
Functional Implant Positioning
Robotic-arm Assisted Execution
Trusted Implants
Australian and New Zealand Experience
Global Experience
Globally over 100,000 robotic-arm assisted knee and hip procedures
Over 10 years of robotic-arm assisted surgery experience
Significant primary clinical research conducted:
Mako PKA resulted in 1% Revision Rate and 92% Patient Satisfaction at 2 Years7.
Mako robotic-arm assisted PKA resulted in lower pain at day 7 and more accurate implant placement than manual PKA in a randomised control trial8.
Mako robotic-arm assisted THA resulted in higher Harris Hip Scores and higher UCLA Activity Scores compared to manual THA at minimum 1-year follow-up9.
Mako robotic-arm assisted TKA resulted in more accurate bone resections and implant placement and less soft tissue damage than manual TKA in a cadaveric study10,11.
Thank you for interest in this product. Your details have been recorded and a representative will be contact with you shortly.
If you would like more information on Stryker's Robotic-Arm Assisted Surgery with Mako, please complete the fields below.